A comparative study of outer membrane proteome between a paired

1 day ago - In the present report we characterized the outer membrane proteome, genomic and lipid A remodelling changes following the evolution a ...
0 downloads 0 Views 3MB Size
Subscriber access provided by Kaohsiung Medical University

Article

A comparative study of outer membrane proteome between a paired colistinsusceptible and extremely colistin-resistant Klebsiella pneumoniae strains Raad Jasmin, Mark A. Baker, Yan Zhu, Mei-Ling Han, Elena K. SchneiderFutschik, Maytham Hussein, Daniel Hoyer, Jian Li, and Tony Velkov ACS Infect. Dis., Just Accepted Manuscript • DOI: 10.1021/acsinfecdis.8b00174 • Publication Date (Web): 20 Sep 2018 Downloaded from http://pubs.acs.org on September 20, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

A comparative study of outer membrane proteome between a paired colistinsusceptible and extremely colistin-resistant Klebsiella pneumoniae strains

Raad Jasim,1 Mark A. Baker,2 Yan Zhu,3 Meiling Han,3 Elena K. Schneider-Futschik,4 Maytham Hussein,4 Daniel Hoyer,4,5,6 Jian Li,3* Tony Velkov4*

1

Drug Development and Innovation, Drug Delivery, Disposition and Dynamics. Monash

Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia. 2Priority Research Centre in Reproductive Science, School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia.3Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia. 4Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria 3010, Australia. 5The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, 30 Royal Parade, Parkville, Victoria 3052, Australia.

6

Department of Molecular Medicine, The

Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.

Correspondence: Tony Velkov, Phone: +61 3 9903 9539. Fax: +61 3 9903 9583. Email: [email protected] or [email protected] * Corresponding authors

Key words: Colistin, Klebsiella pneumoniae, outer membrane proteome.

1 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Author mailing Adresse: Raad Jasim: [email protected] Mark A. Baker: [email protected] Yan Zhu: [email protected] Meiling Han: [email protected] Elena K. Schneider-Futschik: [email protected] Maytham Hussein: [email protected] Daniel Hoyer: [email protected] Jian Li: [email protected] Tony Velkov: [email protected]

2 ACS Paragon Plus Environment

Page 2 of 45

Page 3 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

In the present report we characterized the outer membrane proteome, genomic and lipid A remodelling changes following the evolution of a colistin-susceptible K. pneumoniae ATCC 13883 strain into an extremely colistin-resistant strain. Lipid A profiling revealed the outer membrane of the colistin-susceptible strain is decorated primarily by hexaand hepta acylated lipid A species and a minor tetra-acylated species. In the lipid A profile of the extremely colistin-resistant strain, in addition to the aforementioned lipid A species, the obligatory 4-amino-4-deoxy-L-arabinose modification of the hexa-acylated lipid A was detected. Comparative genomic analysis revealed that the mgrB gene of the colistin-resistant strain is inactivated by a single nucleotide insertion which produces a frame-shift, resulting in premature termination. We also detected two synonymous mutations in the two-component system genes phoP and phoQ. Comparative profiling of the outer membrane proteome of each strain revealed that outer membrane proteins from bacterial stress response, glutamine degradation, pyruvate, aspartate and asparagine metabolic pathways were over represented in the extremely colistinresistant K. pneumoniae ATCC 13883 strain. In comparison, in the sensitive strain, outer membrane proteins from carbohydrate metabolism, H+-ATPase, cell division and peptidoglycan biosynthesis were over represented. Notably, there were no discernible differences between the OmpK35 and OmpK36 major outer membrane porins between the polymyxin-susceptible and -resistant strains suggesting porin deficiency is not involved in the colistin resistance in the ATCC 13883 strain. These findings shed new light on the outer membrane remodelling events accompanying the development of extremely high levels of colistin resistance in K. pneumoniae.

3 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Extremely-drug resistant (XDR) Klebsiella pneumoniae has become one of the deadliest Gram-negative ‘superbugs’.1-3 K. pneumoniae has been the causative pathogen of several nosocomial outbreaks (e.g. pneumonia and bloodstream infections), particularly in immune-compromised patients.4 Carbapenem resistance in K. pneumoniae was first reported in 1996 in New York City and has subsequently spread globally.5-6 In their 2013 Threat Report on Antimicrobial Resistance, the US Centres for Disease Control and Prevention prioritized Carbapenem-Resistant Enterbacteriaceae as an urgent threat.7 Colistin and polymyxin B (Figure 1A) are last-line antibiotics used against XDR K. pneumoniae.8 Polymyxins display excellent in vitro activity against K. pneumoniae;9 with 98.2 % of general clinical strains of K. pneumoniae having susceptibility to polymyxin B and colistin.10-15 Worryingly, XDR strains which are resistant to several antibiotics including the polymyxins have emerged.16-17 The emergence of these XDR strains demands a more in-depth understanding of the mechanism(s) of polymyxin resistance employed by K. pneumoniae to facilitate drug discovery strategies against these problematic XDR Gram-negative pathogens. The Gram-negative outer membrane (OM) acts as a barrier to environmental noxious compounds for the bacterial cell, such as antimicrobials.18-19 The asymmetrical structure of the OM consists of an inner phospholipid leaflet, as well as an outer leaflet that predominantly contains lipopolysaccharide (LPS), proteins, and phospholipids (Figure 1B). LPS is composed of an O-antigen chain, a core-oligosaccharide region and lipid A. Lipid A is embedded within the OM leaflet, functioning as a hydrophobic anchor for the LPS molecule.20 K. pneumoniae also has a capsular polysaccharide coating the surface of the OM, which has been related to polymyxin susceptibility.21-24

4 ACS Paragon Plus Environment

Page 4 of 45

Page 5 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

The precise mechanism of action of polymyxins remains unknown, albeit, a number of models have proposed.25 The agreement is that polymyxins attack the OM and that lipid A is the primary polymyxin target.25 A consensus model termed the ‘selfpromoted uptake’ pathway, purports that the polymyxin exploits its amphipathic properties to facilitate its uptake across the OM.26-28 In the self-promoted uptake model, protonation of free γ-amines on the diaminobutyric acid (Dab) residues of polymyxins at physiological pH, promote an electrostatic attraction to anionic 1- and 4′-phosphates of lipid A.25 The displacement of Mg++ and Ca++ that stabilize the LPS leaflet, then facilitates the insertion of the hydrophobic N-terminal fatty-acyl tail, and D-Phe-L-Leu or D-Leu-L-Leu motifs (of polymyxin B and colistin, respectively) into the OM fatty acyl

layer. Notably, polymyxin nonapeptide which has the N-terminal fatty acyl-Dab1 removed is inactive, which highlights these hydrophobic interactions with lipid A acyl chains are crucial for OM disruption.25-26 The events that follow remain poorly understood, however, it is purported that polymyxins mediated fusion of the inner leaflets of the outer- and cytoplasmic-membranes, inducing phospholipid exchange, cell wall disruption and finally cell death.29-31 Albeit, the relationship between bacterial killing activity, polymyxin resistance and OM remodelling events that perturb the ability of polymyxins to interact with the OM components, remains poorly characterized in K. pneumoniae, and therefore warrants further investigation. Particularly, a proteomic approach has yet to be applied to the OM of polymyxin-resistant K. pneumoniae, where most studies have focused on the roles of LPS and the capsule.21,

23, 32

Outer

membrane proteins (OMPs) play a vital role in bacterial pathogenesis and are involved in adhesion, penetration, complement activation, virulence proliferation and antibiotic

5 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

resistance.19, 22, 33-34 Compared to Escherichia coli, very little is known regarding the OM proteome of K. pneumoniae, let alone its relation to antibiotic resistance. In the present study, we performed a comparative bioinformatic and proteomic analysis for the OM proteome and lipid A profiles of a paired colistin-susceptible and extremely colistin-resistant K. pneumoniae ATCC 13883 strains. The genome of both strains was sequenced, assembled and scanned to generate a comprehensive inventory of polymyxin resistance determinants in each strain. The obtained data sheds new light on the OM remodelling associated with extremely high levels of colistin resistance in K. pneumoniae.

6 ACS Paragon Plus Environment

Page 6 of 45

Page 7 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

Results and Discussion OMP proteome differences between paired colistin-susceptible and extremely colistinresistant K. pneumoniae ATCC 13883 strains There exists a lack of knowledge regarding the OMP of polymyxin resistant K. pneumoniae strains. Campos et. al.,

23

showed that cationic antimicrobial peptide

resistance in K. pneumoniae was partly due to the thickness of capsular polysaccharide. Albeit, more recent studies demonstrated that polymyxin susceptibility in K. pneumoniae was not altered in non-encapsulated mutants.

24, 32

This suggests that apart from the

capsule, other OM components act as an important resistance barrier function against cationic antibiotics such as the polymyxins.18-19 The OMPs of antibiotic resistant35 K. pneumoniae have not been comprehensively studied and there is no established nomenclature.36-38 However, it is known that resistance to polymyxin B and β-lactam antibiotics is associated with the loss of either of the 35 and 36 kDa doublet, respectively termed OmpK35 and OmpK36.22, 33-34, 39-41. The OMP profile of each strain was initially resolved 1D by SDS-PAGE, which revealed five prominent bands with molecular masses of approximately 46, 36 (OmpK36), 35 (OmpK35), 20 and 12 kDa (Figure 2). There were no discernible differences between the OmpK35 and OmpK36 of the polymyxin-susceptible and resistant strain of K. pneumoniae ATCC 13883. This suggests OmpK35 and OmpK36 porin deficiency is not involved in the polymyxin resistance mechanism(s) employed by this strain. Proteomic analysis identified 132 and 110 differentially represented OMPs in colistin-susceptible wild-type and the extremely colistin-resistant mutant, respectively; 53 were commonly found in both strains, with 78 and 31 unique proteins identified in

7 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 45

wild type and the paired resistant strain, respectively (Tables 1,2, S1, S2 & S8). In wild type and mutant, 122 (92.4%) and 103 (93.6%) OMPs were assigned with GO annotations (Table S3). Enrichment analysis revealed that 23 and 13 GO categories were significantly overrepresented in wild type and mutant, respectively. Ten common GO classes were shared by wild type and mutants, including those related to ribosome and outer membrane assembly. Specifically, wild type OMPs uniquely represent the functional classes of energy metabolism, carbohydrate metabolism, and cell division (Tables S4). Whereas the mutant strain contains the proteins related to bacterial stress response (e.g. chaperon proteins HtpG and DnaK) (Table S5). In summary, 47 out of 132 (35.6%) sensitive strain OMPs and 38 out of 110 (34.5%) resistant strain OMPs were mapped onto metabolic pathways of type strain MGH78578, respectively (Tables S1-S3). Enrichment analysis showed that (i) Five metabolic pathways from BioCyc were overrepresented in the sensitive strain, including gluconeogenesis and pyruvate metabolism (Figure 3A & Table S6); (ii) 17 metabolic pathways from BioCyc were overrepresented in the resistant strain, including glutamine degradation, pyruvate, aspartate and asparagine metabolism (Figure 3B & Table S7).

Genetic mutations associated with high-level polymyxin resistance in K. pneumoniae ATCC 13883 Polymyxin resistance in K. pneumoniae involves up-regulation of capsular polysaccharide expression and concomitantly the two-component systems that mediate the modification of lipid A with 4-amino-4-deoxy-L-arabinose.21,

24,

42-49

In K.

pneumoniae, lipid A 4-amino-4-deoxy-L-arabinose modifications is controlled by the two 8 ACS Paragon Plus Environment

Page 9 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

component regulatory systems [PhoPQ-PmrD]-PmrAB in response to high iron, low magnesium and low pH.14, 24 The PhoP-PhoQ regulates the magnesium regulon which can activate the polymyxin B resistance genes (pmrHFIJKLM) encoding 4-amino-4deoxy-L-arabinose biosynthesis and lipid A modification under low magnesium conditions.50 This PhoP-PhoQ system is also connected by the connector proteins PmrD and MgrB which act as feed-back modulators between the PhoPQ and PmrAb.50 PhoPQ regulates PmrD activation, which then complexes to PmrA and thereby prolongs its phosphorylation state, and resistance to polymyxins via the activation of PmrA-PrmB (collectively PmrAB) expression.50 MgrB is the negative regulator of PhoQ, its inactivation due to the insertion elements or frame-shift mutations that lead to premature inactivation (commonly seen in polymyxin-resistant clinical isolates) results in the overexpression of PhoPQ and lipid A modification.14,

50-55

Mutations in PmrAB and

PhoPQ have also been reported in polymyxin-resistant clinical isolates of K. pneumoniae.14,

50-55

In addition to the aforementioned mgrB inactivation and

dysregulation of the two-component systems (TCS), we have previously reported that the under-acylation of lipid A in K. pneumoniae also increases polymyxin susceptibility; which suggest that the modification of lipid A with extra fatty acyl chains is an additonla factor that contributes to polymyxin resistance.32,

56-57

Herein, we sequenced the

genome of both the colistin-susceptible and -resistant K. pneumoniae ATCC 13883 strains and performed a comparative scan of their genomes. Comparative genomic analysis revealed that the mgrB gene of the colistin-resistant strain is inactivated by a single nucleotide insertion at position 40 (39_40insT) resulting in a frame-shift and premature termination (A15SfsX25) (Figure S1). Furthermore, we detected four

9 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 45

synonymous mutations phoP (363T>C and 664T>C) and phoQ (309A>C and 1185C>T) (Figures S2 & S3).50, 58

Lipid A remodelling The fundamental structure of lipid A is composed of a β-1′-6-linked Dglucosamine disaccharide phosphorylated at the 1- and 4′-positions.45 For K. pneumoniae, this backbone is attached to six or seven acyl chains, (R)-3hydroxymyristoyl chains are attached to positions 2, 2′, 3 and 3′ of the glucosamine disaccharide,

while

secondary

myristoyl

chains

are

attached

to

the

(R)-3-

hydroxymyristoyl groups at the 2′ and 3′ positions (2′-3-OH-C14 and 3′-3-OH-C14) and a secondary palmitoyl group attached to the (R)-3-hydroxymyristoyl group at the 2 position (2-3-OH-C16) (Figure 4A).32,

59-60

Additionally, secondary palmitoylation has

been observed at position 2 (2-3-OH-C16) in a minor population of wild-type K. pneumoniae strains.32 In the mass spectrum of lipid A isolated from the polymyxinsusceptible K. pneumoniae ATCC 13883 strain, we can see the two typical hexaacylated lipid A species at m/z 1826 and 1843, and their dephosphorylated forms at m/z 1746 and 1763, respectively (Figure 4A). The two peaks at m/z 1985 and 2065 correspond to the hepta-acylated lipid A with a palmitoyl C16 secondary fatty acyl chain. A tetra-acylated lipid A species at m/z 1377 is also detected, the peak at m/z 1393 is possibly due to one OH adduct (+16). The mass spectrum of lipid A isolated the from the K. pneumoniae ATCC 13883 colistin-resistant strain also displayed major peaks at m/z 1377, 1746, 1763, 1826, 1843, and 2065 corresponding to the aforementioned lipid A species observed in the susceptible strain. The major difference is a peak at m/z

10 ACS Paragon Plus Environment

Page 11 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

1956.85 which is due to a hexa-acylated lipid A species m/z 1825.68 with the addition of one 4-amino-4-deoxy-L-arabinose moiety (+131) (Figure 4B).

Conclusions The present study is the first to reveal that the rubic for when a colistin-susceptible K. pneumoniae strain evolves into an extremely colistin-resistant strain subsumes several key OMP and lipid A perturbations. The limitations of the study is that this extremely colistin resistant phenotype was raised from the K. pneumoniae ATCC 13883 reference strain under laboratory conditions, as opposed to being a pathological isolate from a patient. In addition to the essential 4-amino-4-deoxy-L-arabinose modifications of lipid A due to inactivation of the mgrB TCS negative regulator; our proteomics analysis reveals that OMPs from bacterial stress response, glutamine degradation, pyruvate, aspartate and asparagine metabolic pathways were over represented in the outer membrane proteome of the extremely colistin-resistant K. pneumoniae ATCC 13883 strain.

11 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Experimental Section Materials Colistin sulphate (Batch 20120719) was supplied by Betapharma (Shanghai, China). Stock solutions of colistin (10 mg/L) were prepared in Milli-Q™ water (Millipore, North Ryde, NSW, Australia) and filtered through 0.22 µm syringe filters (Sartorius, Melbourne, Vic, Australia).

Bacterial strains and growth conditions K. pneumoniae ATCC 13883 was obtained from the American Type Culture Collection (Manassas, VA, USA) and used as a reference strain (colistin minimum inhibitory concentration (MIC) = 0.5 µg/mL). A paired colistin-resistant strain (colistin MIC > 256 µg/mL) was selected from this reference strain capable of sustained growth in the presence of 100 µg/mL colistin. MICs for each strain were determined by the broth microdilution method.61

Isolation of outer membrane proteins (OMPs) OMPs were extracted as described previously with minor modifications to the original protocol.62 Briefly, cells from a 600 mL culture of K. pneumoniae ATCC 13883 were pelleted by centrifugation (3200 × g for 10 min at 4°C) and resuspended in 30 mL 10 mM N-2 hydroxy ethyl piperazine-N'-2-ethane sulfonic acid (HEPES), pH 7.4. The cells were lysed by sonication for 10 minutes (pulse at 5 sec/5 s on ice) and then centrifuged at 3200 × g for 10 min at 4°C to remove the cell debris. The supernatant was combined with 7.5 mL of 2% (w/v) N-lauroylsarcosine and incubated for 20 min at 37°C on a

12 ACS Paragon Plus Environment

Page 12 of 45

Page 13 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

shaking platform. The detergent solubilized OMPs were recovered by high speed centrifugation at 75 000 x g for 1 h at 4°C (Beckman, RA 25.50 rotor) and the pellet was resuspended in 30 mL 10 mM HEPES, pH 7.4 and combined with 7.5 mL of 2% (w/v) Nlauroylsarcosine and incubated for 20 min at 37°C for 30 min with shaking. The OMPs were recovered by high speed centrifugation at 75 000 x g for 1 h at 4°C. Following this final ultracentrifugation, the pellet was resuspended in 1500 µL of 10 mM HEPES, pH 7.4 and stored at -20°C.

SDS-PAGE Protein concentration was measured by the Bradford assay and equalized for gel loading. SDS-PAGE was carried out on 4-20% polyacrylamide Tris-Glycine gels and OMPs were detected by Coomassie Blue staining. Gels were cut into uniform 1 mm wide bands and the gel plugs were washed 5 × with 25 mM ammonium bicarbonate in 50% methanol. Gel slices were then incubated overnight in acetonitrile (ACN). ACN was removed and gel plugs were dried and then reconstituted with 50 mM ammonium bicarbonate containing 800 ng of trypsin (Promega, Annandale, NSW Australia). Digestion was allowed to proceed over night at 37oC. Tryptic peptides were extracted twice with 20 µL of 50% ACN/0.1 % trifluoracetic acid and the extracts were combined.

Ultra High Pressure Liquid Chromatography coupled with Mass Spectrometry LC experiments were performed using an Ultimate3000 ultra high-pressure liquid chromatography system (Dionex, Castle Hill, Sydney) equipped with a nano-column C18 PepMap100, 75 µm ID × 150 mm, 3 µm, 100 Ǻ. Mobile phases were as follows: Mobile 13 ACS Paragon Plus Environment

ACS Infectious Diseases 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

phase A: 99.9% water + 0.1% FA (v/v, formic acid); mobile phase B: 20/80 water/ACN (v/v) + 0.08 % FA. Runs were performed at a flow rate of 400 nL/min; gradient, 2-40% B over 45 min, 90% B for 5 min, 4% B for 30 min. CID experiments were performed on a AmaZon ETD Ion Trap (Bruker Daltonik GmbH, Australia) equipped with an onlinenano-sprayer spraying from a 0.090 mm i.d. and 0.02 mm i.d. fused silica capillary. The instrument was set to the flowing mass spectrometric parameters: dry gas temperature, 180°C; dry gas, 4.0 L min-1; nebulizer gas, 0.4 bar; electrospray voltage, 4500 V; highvoltage end-plate offset, -200 V; capillary exit, 140 V; trap drive, 57.4; funnel 1 in 100 V, out 35 V and funnel 2 in 12 V, out 3.3 V; ICC target, 500000; maximum accumulation time, 50 ms. Mass spectra were processed in Data Analysis 4.0, deconvoluted spectra were analyzed with BioTools 3.2 and submitted to Mascot database search. The species subset was set at K. pneumoniae ATCC 13883, parent peptide mass tolerance +/- 0.4 Da, fragment mass tolerance +/- 0.4 Da; enzyme specificity trypsin with 2 missed cleavages considered.

Proteomics analysis Mass spectrometry datasets were combined into compilations using the Protein Extractor functionality of Proteinscape 2.1.0 573 (Bruker Daltonics, Bremen, Germany), that conserves each peptide and their respective score, while combining them to identify proteins with much higher significance vs. using individual searches. False positives were excluded by rejecting peptides with Mascot scores below 40. Protein sequences were manually validated using BioTools (Bruker Daltonics, Bremen, Germany) on a residue-by residue basis using the raw data. In brief, the ion series were inspected to

14 ACS Paragon Plus Environment

Page 14 of 45

Page 15 of 45 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Infectious Diseases

ensure the selected peaks are not base-line, accuracy between the residues is